Dimensional Fund Advisors LP Athenex, Inc. Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.24 - $1.11 $11,259 - $52,074	-46,914 Reduced 37.62%	77,795 $21,000
Q1 2022 May 13, 2022	SELL	$0.79 - $1.59 $68,485 - $137,837	-86,690 Reduced 41.01%	124,709 $103,000
Q4 2021 Feb 09, 2022	SELL	$1.36 - $2.94 $91,090 - $196,915	-66,978 Reduced 24.06%	211,399 $288,000
Q3 2021 Nov 12, 2021	BUY	$2.97 - $4.84 $260,673 - $424,801	87,769 Added 46.05%	278,377 $838,000
Q2 2021 Aug 12, 2021	SELL	$3.71 - $5.13 $272,403 - $376,665	-73,424 Reduced 27.81%	190,608 $881,000
Q1 2021 May 14, 2021	BUY	$4.08 - $14.75 $925,335 - $3.35 Million	226,798 Added 609.12%	264,032 $1.14 Million
Q4 2020 Feb 25, 2021	BUY	$11.06 - $14.01 $411,808 - $521,648	37,234 New	37,234 $412,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.